Replimune Group, Inc. (REPL) Tops Q2 EPS by 14c

Replimune Group, Inc. (NASDAQ: REPL) reported Q2 EPS of ($0.68), $0.14 better than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
• Intuitive Surgical (ISRG) Reiterated at Buy by Stifel After Survey of 100 Robotic Surgeons
• UBS Upgrades FuelCell Energy (FCEL) to Buy, 'we would be buyers ahead of any capacity expansion announcement'